Description
Secnidazole is a nitroimidazole antifungal that also exhibits antibacterial and anti-parasitic activities. Secnidazole inhibits nucleic acid synthesis in microbial cells.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Secnidazole is a nitroimidazole antifungal that also exhibits antibacterial and anti-parasitic activities. Secnidazole inhibits nucleic acid synthesis in microbial cells.
| Cas No. | 3366-95-8 |
|---|---|
| Purity | ≥98% |
| Formula | C7H11N3O3 |
| Formula Wt. | 185.18 |
| Chemical Name | α,2-Dimethyl-5-nitro-1H-imidazole-1-ethanol |
| IUPAC Name | 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol |
| Synonym | Flagentyl |
| Melting Point | 76°C |
| Solubility | Soluble in water. |
| Appearance | Creamy White Crystalline Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Almirall P, Escobedo AA, Ayala I, et al. Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial. J Parasitol Res. 2011;2011:636857. PMID: 22174992.
De Backer E, Dubreuil L, Brauman M, et al. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin Microbiol Infect. 2010 May;16(5):470-2. PMID: 19548924.
GSK-3 and CDK inhibitor.
BRD inhibitor.
Peptide, derivative of AT I, cleavage product o...
Carbonic anhydrase inhibitor.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Mesalazine derivative, sulfa drug; sepiapterin ...
Avermectin; glu-gated Cl- channel activator, Gl...
Thienylbutyl ITC analog.
Endogenous peptide hormone, involved in water h...
Nitrogen mustard, DNA alkylator.
Flavonol glycoside originally found in Epimediu...
Analog of glutamate
Alkaloid originally found in species of Nicotia...
β-lactam cephalosporin; penicillin binding pro...
Dual inhibitor of PI3K and mTOR.
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
KRAS inhibitor
Inhibitor of tropomyosin kinase receptors TRKA,...
Endogenous bombesin-related peptide, involved i...